One-year cardiovascular event rates in outpatients with atherothrombosis

Ph Gabriel Steg1, Deepak L Bhatt, Peter W F Wilson

  • 1Département de Cardiologie, Hôpital Bichat-Claude Bernard, Paris, France. gabriel.steg@bch.aphp.fr

JAMA
|March 22, 2007
PubMed

Insights

Patients with established atherothrombosis face high annual cardiovascular event rates. Having multiple arterial disease locations significantly increases the risk of cardiovascular events within one year.

Area of Science:

  • Cardiovascular Medicine
  • Epidemiology
  • Public Health

Background:

  • Limited data exist on current cardiovascular (CV) event rates in stable atherothrombosis patients in community settings.
  • Differential event rates across coronary artery disease (CAD), cerebrovascular disease (CVD), and peripheral arterial disease (PAD) in a single international cohort remain unevaluated.

Purpose of the Study:

  • To determine contemporary, international, 1-year CV event rates in outpatients.
  • To assess event rates in patients with established arterial disease versus those with multiple atherothrombosis risk factors.

Main Methods:

  • The Reduction of Atherothrombosis for Continued Health (REACH) Registry enrolled 68,236 patients internationally from 2003-2004.
  • The cohort included patients with established atherosclerotic arterial disease (CAD, PAD, CVD) or at least three risk factors.
  • One-year rates of CV death, myocardial infarction (MI), and stroke were analyzed.

Main Results:

  • Overall 1-year CV death, MI, or stroke rates were 4.24%, with 4.69% in established disease patients and 2.15% in high-risk patients.
  • For established disease, rates were 4.52% (CAD), 6.47% (CVD), and 5.35% (PAD).
  • Event rates increased with the number of symptomatic arterial disease locations, from 5.31% (risk factors only) to 26.27% (three locations).

Conclusions:

  • Outpatients with established atherosclerotic arterial disease or at risk experience high annual CV event rates.
  • The presence of multiple arterial disease locations significantly elevates the 1-year risk of CV events.
Abstract

Related Concept Videos

Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.2K
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
1.0K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
948
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741